NEW ORLEANS, Aug. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced it has reopened its laboratory in
Metairie, Louisiana, after successfully completing reconstruction to the
facility following substantial damage to the building and testing equipment
caused by Hurricane Katrina.
Quest Diagnostics' Metairie laboratory performs rapid-response testing as
well as anatomic pathology, microbiology and cytology testing. Additional
testing is performed in the Houston laboratory, which began serving the
Louisiana healthcare market following the hurricane and became home for many
of the company's displaced New Orleans-area employees.
"I want to personally thank our employees in Louisiana and Houston who
showed unwavering commitment to putting patients first," said Michael A. Peat,
Ph.D., Managing Director of the Gulf Coast Business Unit, which serves Houston
and New Orleans.
"As a local employer in New Orleans for more than thirty-five years, Quest
Diagnostics is proud to be a part of a remarkable community that is stepping
up to the task of rebuilding itself in the aftermath of Hurricane Katrina.
Sincere thanks to our valued customers in the healthcare community who stood
by us while our employees implemented back-up plans to ensure that we could
continue to provide needed health testing services."
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2005 Form 10-K and subsequent SEC filings.
SOURCE Quest Diagnostics Incorporated
CONTACT:
Investors: Laure Park, +1-201-393-5030, or
Media: Jennifer
Somers, +1-201-393-5700,
both of Quest Diagnostics Incorporated